Tesamorelin, also known as TH9507, is a synthetic stabilized analog of human growth hormone?releasing hormone (GHRH?1?44) with N?terminal trans?3?hexenoyl modification. This special modification protects the peptide from DPP?IV enzymatic degradation, greatly improving its metabolic stability and half?life while maintaining high binding affinity to GHRH receptors.

As a well?studied GHRH analog, Tesamorelin can activate pituitary GHRH receptors to trigger endogenous growth hormone GH and IGF?1 secretion, widely applied in scientific research covering visceral fat metabolism, lipodystrophy study, hormone axis research, aging?related mechanism and lipid profile investigation.

Our Tesamorelin peptide is synthesized under strict quality control. Each batch is tested by HPLC and MS verification, complete COA document is available upon request. The lyophilized powder is packed in inert?gas sealed vials to minimize moisture exposure during transportation and storage.